Cumberland Partners’s Sanofi SNY Stock Holding History

Cumberland Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-24,750	Closed	-$1.04M	–	65
2016 Q2	$1.04M	Sell	24,750 -750	-3%	-$30.8K	0.15%	47
2016 Q1	$1.02M	Sell	25,500 -1,500	-6%	-$60.3K	0.14%	46
2015 Q4	$1.15M	Buy	27,000 +500	+2%	+$23K	0.15%	47
2015 Q3	$1.26M	Sell	26,500 -200	-0.7%	-$10.2K	0.16%	49
2015 Q2	$1.32M	Sell	26,700 -200	-0.7%	-$10.1K	0.15%	47
2015 Q1	$1.33M	Sell	26,900 -502	-2%	-$24K	0.15%	46
2014 Q4	$1.25M	Sell	27,402 -469,463	-94%	-$22.8M	0.13%	44
2014 Q3	$28M	Sell	496,865 -325	-0.1%	-$17.5K	3.43%	12
2014 Q2	$24.8M	Buy	497,190 +16,975	+4%	+$901K	2.79%	17
2014 Q1	$25.1M	Buy	480,215 +19,695	+4%	+$997K	2.94%	15
2013 Q4	$24.7M	Buy	+460,520	New	+$23.8M	2.68%	18

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Cumberland Partners's SNY Position: Q3 2016 in Review

Cumberland Partners sold out of Sanofi (SNY) in Q3 2016, closing a stake of 24,750 shares — an estimated $1.04M sold.

Cumberland Partners first reported a position in SNY in Q4 2013 and held it in 11 quarters. The position peaked at $28M in Q3 2014. 450 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

Cumberland Partners reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
Cumberland Partners sold 24,750 Sanofi shares in Q3 2016, an estimated $1.04M.
Cumberland Partners first reported a position in Sanofi in Q4 2013 and held it in 11 quarters.
Cumberland Partners's Sanofi position peaked at $28M in Q3 2014.
450 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Cumberland Partners's 13F filing for Q3 2016, filed 14 Nov 2016.